Stock RVV REVIVE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Revive Therapeutics Ltd.

Equities

RVV

CA7615161030

Market Closed - Canadian Securities Exchange
Other stock markets
 18:24:29 10/05/2024 BST 		5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for Revive Therapeutics Ltd. -16.67% -16.67%
04-23 FDA Grants Revive Therapeutics Type C Meeting Request For Bucillamine Study to Treat Long COVID MT
04-23 Revive Therapeutics Brief: Announcing Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. RVV Stock
  4. News Revive Therapeutics Ltd.
  5. Official Publications